Centre Testing International Group Co. Ltd. Stock
Stocks
300012
CNE100000GV8
Business Support Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.06 CNY | -1.47% |
|
-0.64% | +3.76% |
| 04-28 | Bioduro and Cti Biotechnology Form Strategic Partnership for Preclinical Drug Development | CI |
| 04-21 | Declaration of Voting Results by Centre Testing International | CI |
| Market Cap | 23.52B 3.46B 3.03B 2.78B 2.59B 4.91B 330B 4.99B 33.45B 12.96B 162B 13B 12.72B 557B | P/E 2026 * |
20.2x | P/E 2027 * | 17.5x |
|---|---|---|---|---|---|
| Enterprise Value | 21.72B 3.2B 2.79B 2.57B 2.39B 4.54B 304B 4.61B 30.89B 11.97B 149B 12.01B 11.74B 514B | EV / Sales 2026 * |
2.87x | EV / Sales 2027 * | 2.51x |
| Free-Float |
79.89% | Yield 2026 * |
1.29% | Yield 2027 * | 1.51% |
| 1 day | -1.47% | ||
| 1 week | -0.64% | ||
| Current month | +1.44% | ||
| 1 month | -2.77% | ||
| 3 months | -2.77% | ||
| 6 months | +3.76% | ||
| Current year | +3.76% |
| 1 week | 13.24 | 15.3 | |
| 1 month | 13.24 | 15.3 | |
| Current year | 13.24 | 17.97 | |
| 1 year | 11.56 | 17.97 | |
| 3 years | 9.48 | 21.1 | |
| 5 years | 9.48 | 31.15 | |
| 10 years | 3.36 | 35.3 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/12/22 | Sell | 100,000 | 0.0066% | |||
| 29/12/22 | Sell | 230,000 | 0.0151% | |||
| 29/12/22 | Sell | Chairperson | 750,000 | 0.0492% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.47% | -0.64% | +21.21% | -27.90% | 3.51B | ||
| +1.18% | +1.99% | +14.39% | +12.90% | 23.26B | ||
| -0.70% | +1.21% | +36.86% | - | 19.55B | ||
| -2.90% | +2.68% | +89.24% | +56.99% | 3.78B | ||
| -4.05% | +3.52% | +244.06% | +238.05% | 2.69B | ||
| +1.83% | +5.11% | +265.10% | +344.04% | 2.1B | ||
| +1.38% | -0.98% | -28.36% | - | 1.8B | ||
| +2.87% | +4.41% | -29.59% | -39.27% | 1.8B | ||
| +1.49% | +3.69% | +9.39% | -4.93% | 1.7B | ||
| +1.62% | -0.85% | +0.33% | -4.12% | 1.43B | ||
| Average | +0.10% | +3.69% | +62.26% | +71.97% | 6.16B | |
| Weighted average by Cap. | -0.03% | +1.41% | +42.08% | +42.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.57B 1.11B 974M 894M 834M 1.58B 106B 1.61B 10.77B 4.17B 52.04B 4.18B 4.09B 179B | 8.52B 1.25B 1.1B 1.01B 939M 1.78B 119B 1.81B 12.12B 4.7B 58.58B 4.71B 4.61B 202B |
| Net income | 1.19B 175M 153M 140M 131M 248M 16.66B 252M 1.69B 655M 8.17B 657M 643M 28.15B | 1.37B 202M 177M 162M 151M 287M 19.24B 291M 1.95B 757M 9.44B 759M 742M 32.51B |
| Net Debt | -1.8B -265M -232M -213M -198M -376M -25.24B -382M -2.56B -993M -12.38B -996M -974M -42.66B | -2.12B -312M -273M -250M -233M -443M -29.7B -450M -3.01B -1.17B -14.57B -1.17B -1.15B -50.2B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/07/26 | CN¥14.06 | -1.47% | 36,335,100 |
| 02/07/26 | CN¥14.27 | -5.12% | 48,377,561 |
| 01/07/26 | CN¥15.04 | +8.51% | 57,961,432 |
| 30/06/26 | CN¥13.86 | +0.29% | 26,476,136 |
| 29/06/26 | CN¥13.82 | +1.92% | 31,701,793 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 300012 Stock
Select your edition
All financial news and data tailored to specific country editions
















